Position in LH
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$407,400
+$73,621 QoQ
Shares Held
1,455
+16.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#623
of 1,040 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CX Institutional holds $23,764,903 across 15 Diagnostics & Research names. LH ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
19,587 | $9,820,138 | |
| 2 | DHR |
Danaher Corp /De/
|
41,221 | $7,851,776 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
2,962 | $1,568,645 | |
| 4 | DGX |
Quest Diagnostics Inc
|
6,874 | $1,456,944 | |
| 5 | A |
Agilent Technologies, Inc.
|
4,448 | $590,827 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
2,340 | $452,134 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
1,455 | $407,400 | |
| 8 | RVTY |
Revvity, Inc.
|
3,344 | $372,053 |
All Filings in LH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $407,400 | 1,455 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $333,779 | 1,251 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $255,144 | 1,017 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $279,883 | 975 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $221,558 | 844 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $204,345 | 878 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $214,414 | 935 | Shares | Sole | 2025-01-21 | |
| No filing history on record for this holder in this stock. | ||||||